Pricing Log in Create free account

Neurogene Inc. (NGNE) vs Shattuck Labs, Inc. (STTK)

Neurogene Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Neurogene Inc. and Shattuck Labs, Inc. are of similar size ($505.9M and $493.9M). Across the 9 metrics below, Shattuck Labs, Inc. leads on 6 and Neurogene Inc. on 3.

Valuation

Metric NGNE STTK Biotechnology median
P/E n/m n/m 10.96
P/S n/m 160.15 9.52
P/B 2.64 4.64 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales n/m 125.13 9.00
Earnings yield (19.78%) (10.36%) (32.09%)
Free cash flow yield (15.29%) (5.55%) (22.62%)

Profitability

Metric NGNE STTK Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (45.32%) (47.20%) (50.12%)
Return on assets (41.02%) (43.93%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NGNE STTK Biotechnology median
Revenue growth (TTM) — 106.48% 6.78%
EPS growth (last fiscal year) 0.93% 53.02% 29.88%
Revenue growth, 5-year CAGR — (36.82%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NGNE STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.64 15.80 4.74
Net debt to EBITDA 2.57 1.62 1.01

Dividend

Metric NGNE STTK Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric NGNE STTK Biotechnology median
Market cap 505.89m 493.93m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack